<!-- PageNumber="760" -->
<!-- PageHeader="SURGICAL AUDIT OF BREAST CANCER" -->

non-indigenous cases. BreastScreen Cairns screened 2310 indige-
nous women in the 5-year period of this study. Their detection
rate (per 1000) was 3.9 among indigenous women compared with
3.77 among all women (BreastScreen Queensland Cairns Service,
unpubl. data, 2001). The districts of drainage of the Cairns Base
Hospital, BreastScreen Cairns and the Australian Bureau of Statistics survey may all differ slightly.

Despite this, indigenous women presented with larger tumours
and a higher incidence of nodal and metastatic disease, although
these figures did not all reach statistical significance perhaps
because of the small numbers in this study. These figures may be
extrapolated to support epidemiological findings that breast
cancer in indigenous women has a higher mortality rate.2

Despite larger tumour size, indigenous women were consid-
ered suitable for breast conservation surgery at a rate similar to
the non-indigenous population. All patients received adjuvant
therapy as directed by visiting oncologists although completion
was not recorded in all cases. As such, it would be hoped that
stage-for-stage, indigenous women will have the same choices
and outcomes as non-indigenous women.

According to the Australian Bureau of Statistics there are more
than 23000 Aboriginal and Torres Strait Islander women aged 40
and over.5 This belies the often claimed notion that the age profile
of the Aboriginal and Torres Strait Islander reduces the impor-
tance of breast cancer.

The benefit from this audit study will be the intention for all
future patients to be included prospectively in the Royal Australasian College of Surgeons' Breast Cancer Surgical Audit. This
will allow the trends found in the present study to be followed to
see if the apparent later presentation of indigenous patients continues. If so, strategies currently in place in Far North Queensland
to detect early breast cancer can then be reviewed. If, with time,
future audits show no difference in presentation, this information
can be used to support the continued use of these strategies (such
as those used by BreastScreen Queensland). In 5 to 10 years,

audits will also allow a review of mortality rates in the two
groups. From these data, we will be able to ensure that indigenous
women can expect the same outcomes as other women in regional
Australia.


# ACKNOWLEDGEMENTS

The authors wish to thank Dr David Whiteman (Queensland
Institute of Medical Research) for assistance with statistical analysis and Mr Keith Coakley of BreastScreen Cairns.


# REFERENCES

1\. National Breast Cancer Centre. NHMRC National Breast Cancer
Centre Breast Cancer and Aboriginal and Torres Strait Islander
Women Executive Summary. Canberra: National Breast Cancer
Centre, 15 July 1999. Available from URL: http://www.nbcc.org.au
Accessed on: 20 January 2002.

2\. Australian Institute of Health and Welfare. Australia's Health
1992: The Third Biennial Report of the Australian Institute of
Health and Welfare. Canberra: AGPS, 1992.

3\. Scrimgeour D, Bartlett B. Cancer Screening in Aboriginal Popu-
lations. Cancer Forum 1998; 22: 36-9.

4\. Kricker A, Jeffs P. Breast Cancer in Australian Women 1921-
1994\. Canberra: Australian Institute of Health and Welfare,
1996\.

5\. Australian Bureau of Statistics. National Aboriginal and Torres
Strait Islander and Torres Strait Islander Survey. Canberra: Aus-
tralian Bureau of Statistics, 1995 (Catalogue No. 4190.0).

6\. McMichael C, Kirk M, Manderson L, Hoban E, Potts H. Indige-
nous women's perceptions of breast cancer diagnosis and
treatment in Queensland. Aust. N. Z. J. Pub. Health 2000; 24:
515-19.

7\. Kirk M, McMichael C, Potts H, Hoban E, Hill D, Manderson L.
Breast Cancer: Screening, Diagnosis, Treatment and Care for
Aboriginal Women and Torres Strait Islander Women in
Queensland Report. Brisbane: Queensland Health, 2000.